Second generation human papillomavirus (HPV) vaccine for broad-spectrum protection against HPV-induced skin and mucosal neoplasia
Dauer: 60 Monate, Fördersumme: € 800.000
Enhanced Therapy for Liver Malignancies based on Optimised Secondary Particle Radiotherapy and Bio-pharmacokinetic Modelling
Dauer: 48 Monate, Fördersumme: € 806.600
Quantitative MRI assessment of cartilage glyco-saminoglyacan content in the ankle
Dauer: 54 Monate, Fördersumme: € 508.800
Serum-Autoantibody testing for early diagnosis of Breast Cancer
Dauer: 42 Monate, Fördersumme: € 579.300
Tumor-infiltrating CD20+ B cells: Promoters of human melanoma?
Dauer: 60 Monate, Fördersumme: € 767.400
A new treatment concept for lung injury
Dauer: 57 Monate, Fördersumme: € 492.800